Physician profile
Michael S Williams
NPI 1962561746
$3,294.79
in general payments reported to CMS, 2019-2025
17 companies · $569 in 2025
The $569 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $642 · 2020: $190 · 2021: $128 · 2022: $521 · 2023: $521 · 2024: $724 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,814.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,095.49 | 2022-2025 | Infuse, Vyzulta, Lotemax |
| Alcon Vision LLC | $434.16 | 2019-2025 | Precision7, Precision 1, Total30 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $389.52 | 2019-2021 | |
| Coopervision INC. | $306.96 | 2019-2025 | Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $292.23 | 2019-2023 | Acuvue |
| Oyster Point Pharma, INC. | $182.52 | 2023-2024 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $124.99 | 2022 | |
| Dompe US, INC. | $123.14 | 2024 | Oxervate |
| Regeneron Healthcare Solutions, INC. | $111.40 | 2019 | |
| Lkc Technologies, INC. | $55.01 | 2025 | |
| Novartis Pharmaceuticals Corporation | $44.73 | 2020-2021 | |
| Horizon Therapeutics Plc | $36.89 | 2022 | |
| Biotissue Holdings INC. | $22.32 | 2022 | |
| Kala Pharmaceuticals, INC. | $21.06 | 2021 | |
| Allergan, INC. | $20.77 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $17.13 | 2025 | Xdemvy |
| Thea Pharma INC. | $16.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.